Drug Liability Attorneys in New York City - Call (888) 260-0473
Have you used Zantac and recently been diagnosed with cancer of the digestive system? You can contact our firm and ask questions about this very new medical development and learn about your potential rights. The online Valisure Pharmacy published a major report on the digestive cancers associated with Zantac and oncologist Dr. Lior Braunstein studies Zantac use and cancer at Memorial Sloan Kettering.
The common over-the-counter drug known as Zantac has been recalled by Novartis, Dr. Reddy, and other companies. The leading cause of the recall was the carcinogen N-Nitrosodimethylamine (NDMA) being found within the drug. In recent litigation involving the recall of blood pressure medications, which has the same impurity as Zantac, it has been discovered that this carcinogen is known as NDMA had led to cancer of the digestive tract. At Rheingold Giuffra Ruffo & Plotkin LLP, our New York defective drug lawyers handle cases directly and do not refer them to other firms.
Zantac’s Original Maker Halts Shipping on Carcinogen Concern
New York City Attorneys Speaking with Zantac Users & Filing Zantac Cancer Lawsuits
Have you been diagnosed with cancer after prolonged use of over-the-counter or prescription Zantac (ranitidine)? Recent studies suggest there is a positive correlation between Zantac use and the formation of carcinogens within the human body. You may be able to file a Zantac cancer lawsuit if you developed cancer while consuming Zantac for a prolonged period of time. Use the contact form on this page for a free case evaluation by one of our experienced dangerous drug attorneys. You may also call our office directly at (888) 260-0473 to discuss your Zantac cancer lawsuit and possible settlement. At Rheingold Giuffra Ruffo & Plotkin LLP, our New York defective drug lawyers handle cases directly and do not refer them to other firms.
Common cancers associated with Zantac use may include:
- Stomach cancer
- Kidney cancer
- Colorectal cancer
- Esophageal cancer
- Small Intestine cancer
- Liver cancer
- Blood cancers: Leukemia, Non-Hodgkin’s Lymphoma, Multiple Myeloma
- Pancreatic cancer
- Brain cancer
- September 9, 2019, Valisure LLC and ValisureRX LLC filed a Citizen Petition with the Food and Drug Administration (FDA) requesting ranitidine drugs to be recalled from the U.S. market.
- October 2, 2019, CNN reported that Walmart, CVS, and Walgreens will remove Zantac and other ranitidine drugs from store shelves.
- October 18. 2019 Sanofi (the makers of Zantac) issue a voluntary recall of Zantac over-the-counter medication in the United States and Canada.
Common Zantac Brands
Zantac was originally prescription-only, and up to 300 mg. Zantac has also become available over-the-counter in doses of 150 mg and lower. Our firm has a product identification brochure to help you identify which products you used. Some of the more common brands are:
- Zantac 150 Tablets
- Zantac 150 Maximum Strength
- Zantac 150 Maximum Strength Cool Mint
- Zantac 75 Tablets
- Wal-Zan 150
- Wal-Zan 75
- Heartburn Relief (ranitidine)
- Acid Reducer (ranitidine)
- Acid Control (ranitidine)
Firm Experienced in Dealing with Pharmaceutical Companies
Our New York dangerous drug lawyers perform a rigorous investigation of the impact this injury has had on clients and their families, both medically and financially. We have access to expert witnesses in pharmacology and other relevant fields who help us determine how dangerous drugs contributed to your injuries and who is liable for the damages. We offer every client personal, individual and attentive client service and dedication to results. Furthermore, through our extensive litigation against Japanese pharmaceutical companies, we are experienced with lawsuits involving dangerous drugs, and foreign pharmaceutical.
Our New York defective drug attorneys are able to handle a wide range of drug liability claims, including those involving the over the counter medication Zantac. Call (888) 260-0473 for a free case evaluation.